Professional Documents
Culture Documents
American Cancer Society. 2013. Cancer Fact and Figures 2013. 4-5
Anindhita T. 2012. Hambatan Heparin terhadap Tissue Factor dan
Vascular Endothelial Growth Factor melalui Tissue Factor Pathway
Inhibitor di Jaringan Meningioma. Disertasi, Universitas Indonesia.
Berger MS, Prados, MD. 2005. Textbook of Neurooncology: Diagnostic
Imaging. Elsevier Saunders. Pennsylvania:19-27.
Blom JW, Vanderschoot JPM, Oostindier MJ, Osanto S, van der Meer
FJM, Rosendaal FR. 2006. Incidence of venous thrombosis in a
large cohort of 66 329 cancer patients: results of a record linkage
study. J Thromb Haemost 2006; 4: 529535.
Budikayanti A, Ranakusuma TAS, Bustami M, Prihartono J. 2009.
Penilaian Status Koagulasi dan Profil Karotis sebagai Komplikasi
Serebrovaskular pada Tumor Susunan Saraf Pusat.
Neurona
Dahlan, MS. 2010. Besar Sampel dan Cara Pengambilan Sampel dalam
Penelitian Kedokteran dan Kesehatan. Salemba Medika: 20-21.
Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. 1999. The
conditional probability of survival of patients with primary malignant
brain tumors: surveillance, epidemiology, and end results (SEER)
data. Cancer 1999;85(2):485-91.
Das S, Marsden PA. 2013. Angiogenesis in Glioblastoma. N Engl J Med
369; 16: 1561-1563.
Eppy, Harsal A, Amin Z, Nainggolan G, Atmakusuma D. 2007.
Hiperkoagulasi pada Pasien Kanker Paru Bukan Sel Kecil. Maj
Kedokt Indon 2007; 57(2): 41-46.
Furie B, Furie BC. 2008. Mechanism of Thrombus Formation. N Engl J
Med 2008; 359: 938-949.
Goetz P, Ebinu JO, Roberge D, Zadeh, G. 2012. Current Standart in the
Management of Cerebral Metastases. International Journal of
Surgical Oncology;2012: 1-10.
Hakim A. A. 2005. Kasus-Kasus Tumor Otak di Rumah Sakit H. Adam
Malik dan Rumah Sakit Haji Medan Tahun 2003-2004. Majalah
Kedokteran Nusantara 2005; 38(3): 242-245.
Dokter
Spesialis
Saraf
Indonesia
2013
(PIN
operasi
kraniotomi
pada
DR.CIPTOMANGUNKUSUMO.
tumor
Abstrak
otak
Tesis,
di
RSUPN
Universitas
Indonesia.
Taylor FB , Toh CH, Hoots WK. 2011. Towards definition, clinical and
laboratory criteria, and a scoring system for disseminated
intravascular coagulation. Thromb Haemost. 2001;86:1327-1330.
Varky A. 2007. Trosseaus Syndrome: Multiple definitions and multiple
mechanism. Blood; 110(6): 1723-1729.
Vasquez V, Liang X, Horndahl JK, Janesh VK, Smeds E, Foster TJ et al.
2011. Fibrinogen is a ligand for the S. aureus MSCRAMM Bbp
(Bone
sialoprotein-binding
protein
).
American
Society
for